AFT Pharmaceuticals (ASX:AFP) Total Stockholders Equity : A$68.2 Mil (As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is AFT Pharmaceuticals Total Stockholders Equity?

AFT Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Sep. 2023 was A$68.2 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. AFT Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2023 was A$0.65. The ratio of a company's debt over equity can be used to measure how leveraged this company is. AFT Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2023 was 0.50.

AFT Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for AFT Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals Total Stockholders Equity Chart

AFT Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Stockholders Equity

Get a 7-Day Free Trial

4.91

16.81

33.87

52.85

68.13

AFT Pharmaceuticals Semi-Annual Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Stockholders Equity	Get a 7-Day Free Trial											39.65	52.85	51.82	68.13	68.21

AFT Pharmaceuticals (ASX:AFP) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

AFT Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(68.207	-	0)	/	104.866
	=	0.65

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

AFT Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	33.797)	/	68.207
	=	0.50

AFT Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AFT Pharmaceuticals (ASX:AFP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (ASX:AFP) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

AFT:New Zealand

Address

129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622

Website

https://www.aftpharm.com

AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.

AFT Pharmaceuticals (ASX:AFP) Headlines

No Headlines